GSA CAPITAL PARTNERS LLP - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$218
-33.5%
70,583
-3.1%
0.02%
-42.4%
Q2 2023$328
+21.0%
72,834
+53.0%
0.03%
+22.2%
Q1 2023$271
-6.2%
47,614
-0.4%
0.03%
-25.0%
Q4 2022$289
-99.9%
47,801
-11.8%
0.04%
-23.4%
Q3 2022$358,000
+87.4%
54,173
+47.9%
0.05%
+62.1%
Q2 2022$191,000
+19.4%
36,626
+57.9%
0.03%
+38.1%
Q1 2022$160,00023,2010.02%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$287,436,0002.91%
Baker Brothers Advisors 10,123,824$289,845,0001.27%
Logos Global Management LP 400,000$11,452,0000.96%
Rock Springs Capital Management LP 382,359$10,947,0000.22%
HHLR ADVISORS, LTD. 583,333$16,701,0000.17%
Virtus ETF Advisers LLC 6,622$190,0000.08%
Jump Financial, LLC 13,700$392,0000.04%
ARS Investment Partners, LLC 7,400$212,0000.02%
FEDERATED HERMES, INC. 336,100$9,623,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,287,735$36,867,853,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders